Clinical Trial Update: COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

View source ↗

Summary

This clinical trial update confirms the completion of a biomarker study evaluating a COVID-19 vaccine in individuals with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Columbia University | Conditions: Multiple Sclerosis, COVID-19 | Status: COMPLETED